Predicting factors of hypoglycaemia in elderly type 2 diabetes patients: Contributions of the GERODIAB study

Autor: L. Bordier, M. Buysschaert, B. Bauduceau, J. Doucet, C. Verny, V. Lassmann Vague, J.P. Le Floch, B Bauduceau, J-F Blicklé, I Bourdel-Marchasson, T Constans, J Doucet, A Fagot-Campagna, E Kaloustian, V Lassmann-Vague, P Lecomte, D Tessier, C Verny, U Vischer, H Affres, M Alix, F Archambeaud, Z Barrou, P Beau, S Beltran, C Benoit, J-P Beressi, F Bernachon, C Berne, G Berrut, A Blaimont, J-F Blickle, M Boda-Buccino, J Bohatier, P Böhme, L Bordier, K Bouchou, B Bouillet, F Bouilloud, R Bouix, E Boulanger, C Bourgon, E Bourrinet, P Brocker, I Bruckert, C Capet, C Carette, B Cariou, A Carreau, C Chaillou Vaurie, S Chamouni, C Ciangura, C Collet-Gaudillat, M-E Combes-Moukhovsky, M Cordonnier, A Cuperlier, D Dambre, J D'Avigneau, P De Botton, V Degros, F Delamarre-Damier, S Denat, F Desbiez, B Deumier, F Dorey, E Dresco, A Drutel, E Du Rosel De Saint Germain, D Dubois-Laforgue, B Duly-Bouhanick, O Dupuy, L Dusselier, S Faucher-Kareche, S Fendri, P Fontaine, S Galinat, A Gentric, H Gin, F Glaise, T Godeau, B Gonzales, I Got, B Guerci, P-J Guillausseau, S Hadjadj, Y Hadjali, M Halbron, S Halimi, C Halter, H Hanaire, V Hardy, A Hartemann-Heurtier, J-P Haulot, F Hequet, M Issa-Sayegh, P Jan, N Jeandidier, H Joseph-Henri, I Julier, V Kerlan, T Kharitonnoff, M Ladsous, L Lahaxe, M-P Lamaraud, E Lassenne, J-M Lecerf, I Leroux, S Lesven, M Levy, S Lopez, F Makiza, P Manckoundia, C Marquis Pomeau, H Mayaudon, S Micheli, R Mira, F Monnier, H Mosnier-Pudar, N Neri, I Normand, M Paccalin, C Pagu, D Paris, A Penfornis, J-L Perie, J-M Petit, G Petit-Aubert, B Pichot-Duclos, L Pivois, M Popelier, G Poulingue, M Priner, V Quipourt, M Rasamisoa, J-L Richard, V Rigalleau, N Roudat, C Sanz, J-M Serot, D Sifi, S Sirvain, A Slimani, E Sonnet, C Sosset, A Soualah, A Stroea, I Tauveron, J Timsit, M Tschudnowsky, A Vambergue, O Verier-Mine, M Virally

Publikováno v: Diabetes & Metabolism. 41:301-303

The burden of hypoglycaemia is important, particularly in elderly type 2 diabetes (T2D) patients. Unfortunately, however, few studies are available concerning this population. GERODIAB is a prospective, multicentre, observational study that aims to d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e6d98da39b0ea875cef75cb76906ced
https://doi.org/10.1016/j.diabet.2015.03.001

Medical treatments of elderly, French patients with type 2 diabetes: results at inclusion in the GERODIAB Cohort.

Autor: Doucet, Jean A.¹, Bauduceau, Bernard², Le Floch, Jean‐Pierre³, Verny, Christiane⁴, Blicklé, JF, Bourdel‐Marchasson, I, Constans, T, Fagot‐Campagna, A, Lassmann‐Vague, V, Vischer, U, Affres, H, Alix, M, Archambeaud, F, Barrou, Z, Beau, P, Beltran, S, Benoit, C, Beressi, J‐P, Bernachon, F, Berne, C

Publikováno v: Fundamental & Clinical Pharmacology. Feb2016, Vol. 30 Issue 1, p76-81. 6p.

Cardiovascular Complications Over 5 Years and Their Association With Survival in the GERODIAB Cohort of Elderly French Patients With Type 2 Diabetes.

Autor: Bauduceau B; Endocrinology, Bégin Hospital, Saint Mandé, France., Le Floch JP; Diabetology-Endocrinology, Villecresnes Medical Hospital, Villecresnes, France jplefloch@dietvill.com., Halimi S; Diabetology, Endocrinology, Grenoble Alpes University, Grenoble, France., Verny C; Gerontology, Bicêtre University Hospital, Le Kremlin-Bicêtre, France., Doucet J; Internal Medicine, Geriatrics and Therapeutics, Saint Julien Hospital, Rouen University Hospital, Rouen, France.

Publikováno v: Diabetes care [Diabetes Care] 2018 Jan; Vol. 41 (1), pp. 156-162. Date of Electronic Publication: 2017 Nov 07.